Kazia Therapeutics (KZIA) Non-Current Assets (2009 - 2025)
Kazia Therapeutics (KZIA) posted Non-Current Assets of $739642.8 for Q4 2025, up 2.52% on a QoQ basis from $721458.3 in Q2 2025, and down 92.2% year-over-year from $9.5 million in Q4 2024.
Kazia Therapeutics (KZIA) Non-Current Assets (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $739642.8 for Q4 2025.
- Quarterly Non-Current Assets fell 92.2% year-over-year to $739642.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $739642.8 (down 92.2% YoY) and the FY2025 annual result came in at $721458.3, down 92.91% from the prior year.
- Non-Current Assets was $739642.8 for Q4 2025 at Kazia Therapeutics, up from $721458.3 in the prior quarter.
- Across five years, Non-Current Assets topped out at $22.1 million in Q2 2021 and bottomed at $721458.3 in Q2 2025.
- A 5-year average of $11.9 million and a median of $11.1 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets jumped 168.27% — and 2025, when it sank 92.91%.
- Kazia Therapeutics' Non-Current Assets stood at $20.4 million in 2021, then dropped by 29.3% to $14.4 million in 2022, then decreased by 25.98% to $10.7 million in 2023, then dropped by 11.01% to $9.5 million in 2024, then sank by 92.2% to $739642.8 in 2025.
- Business Quant data shows KZIA's Non-Current Assets at $739642.8 in Q4 2025, $721458.3 in Q2 2025, and $9.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 739,642.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 739,642.85 |
| Jun 30, 2025 | 721,458.25 |
| Dec 31, 2024 | 9.49 Mn |
| Jun 30, 2024 | 10.18 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Jun 30, 2023 | 11.57 Mn |
| Dec 31, 2022 | 14.40 Mn |
| Jun 30, 2022 | 18.94 Mn |
| Dec 31, 2021 | 20.37 Mn |
| Jun 30, 2021 | 22.10 Mn |
| Dec 31, 2020 | 13.92 Mn |
| Jun 30, 2020 | 8.24 Mn |
| Dec 31, 2019 | 8.85 Mn |
| Jun 30, 2019 | 9.57 Mn |
| Dec 31, 2018 | 12.04 Mn |
| Jun 30, 2018 | 14.32 Mn |
| Jun 30, 2017 | 12.34 Mn |
| Dec 31, 2016 | 17.30 Mn |
| Jun 30, 2016 | 12.27 Mn |
| Dec 31, 2015 | 1.07 Mn |